Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

FDA highlights risks of evaluating blood pressure with unauthorized medical devices
The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.
Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
Health systems use AI to target patients who may have elevated Lp(a) levels
"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.
Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.

Restricting salt intake too much may backfire for some heart patients

Limiting salt is a common recommendation for patients hoping to improve their heart health or lose weight. According to a new analysis of more than 1,700 patients, however, going too far with such restrictions can lead to worse outcomes.

healthcare value value-based care money dollar

Telehealth provider raises $20M to improve cardiac rehab enrollment

The company hopes this investment will help bridge gaps in care for underserved groups.

“We need an answer now”: Cardiologist awarded $2.3M to study cannabis use and heart health in people living with HIV

The four-year analysis will use cardiac MRI scans to closely monitor the heart health of people living with HIV who regularly use cannabis to treat their symptoms.

Most Americans, especially men, have suboptimal heart health

The American Heart Association has published a new analysis focused on diet, sleep, BMI, blood pressure and other crucial factors among adults and children in the United States.

Cancer survivors face a 42% higher risk of CVD

More aggressive CVD prevention tactics may make sense for people who have had certain types of cancer.

. Plaque erosion detection by the proposed AI algorithm in four cases, with each column showing one case. From top to bottom are the original images, ground truth, and predicted plaque erosion by our proposed method respectively.

New AI model detects plaque erosion in arteries

Detecting plaque erosion can offer an early warning sign of restricted blood flow to the heart, which can cause heart attacks.

Vitamins for CVD prevention? Not so fast, says USPSTF

According to new recommendations from the USPSTF, there are two specific vitamins—vitamin E and beta-carotene—that should not be taken to prevent CVD. When it comes to other vitamins, however, more evidence is still needed.

Statin use may slow progression of arterial stiffness

Continuous and high-adherent statin users had lower baseline arterial stiffness, which also grew more slowly over time.

Heart Health

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Health systems use AI to target patients who may have elevated Lp(a) levels

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?